ICD-10-CM Billable Code

K75.3

Granulomatous hepatitis, not elsewhere classified

Clinical Classification Guidelines

Excludes Type 1

  • acute or subacute hepatitis (K72.0-)
  • chronic hepatitis NEC (K73.-)
  • viral hepatitis (B15-B19)

Medical Intelligence & Overview

Granulomatous hepatitis is a liver condition characterized by the formation of granulomas—small areas of inflammation caused by immune cells gathering in the liver tissue. This condition is classified under ICD-10 code K75.3 and is considered a non-specific diagnosis, meaning it may be associated with various underlying causes. Recognizing the features and potential origins of granulomatous hepatitis is important for appropriate medical evaluation and management.

Causes & Symptoms

Clinical Causes: Infections, such as tuberculosis, histoplasmosis, or other fungal and bacterial infections Autoimmune diseases like sarcoidosis or autoimmune hepatitis Certain drug reactions or medications Exposure to environmental toxins or chemicals Chronic inflammatory conditions affecting the liver Unknown or idiopathic causes where no specific origin is identified

Key Symptoms: Fatigue and general malaise Lack of appetite or weight loss Right upper quadrant abdominal pain or tenderness Jaundice (yellowing of the skin and eyes) Fever and night sweats Persistent or intermittent fever Swelling in the abdomen due to liver enlargement Musculoskeletal discomfort in some cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing granulomatous hepatitis involves a combination of clinical evaluation, blood tests, imaging, and tissue analysis. Key steps include: - Blood tests to detect signs of inflammation, liver function abnormalities, and potential infectious agents - Imaging studies like ultrasound or CT scans to assess liver size and structure - Liver biopsy to obtain tissue samples, which are examined microscopically for granulomas and signs of underlying causes - Special stains or cultures to identify infectious organisms - Serologic tests to evaluate for autoimmune markers or specific infections The diagnosis often requires exclusion of other liver conditions and a comprehensive assessment of the patient’s medical history and risk factors.

Treatment Protocols: Management of granulomatous hepatitis depends on its underlying cause. Common approaches include: - Antibiotics or antifungal medications if an infection is identified - Corticosteroids or immunosuppressive drugs for autoimmune-related causes - Discontinuation of potential offending drugs or exposure to toxins - Supportive care to address symptoms such as pain or fatigue - Regular monitoring of liver function and response to therapy In some cases, the condition may resolve on its own, while persistent or severe cases might require long-term management and specialized care. Tailored treatment plans are essential based on the specific diagnosis and patient circumstances.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is K75.3 a billable ICD-10 code?
Yes, K75.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report K75.3?
Clinical documentation must specify the nature of Granulomatous hepatitis, not elsewhere classified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

granulomatous